Worth Venture Partners, LLC Rvl Pharmaceuticals PLC Transaction History

Worth Venture Partners, LLC

  • $12 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$0.56 - $1.17 $24,738 - $51,684
-44,175 Reduced 13.68%
278,654 $156,000
Q1 2023

May 15, 2023
SELL
$1.02 - $1.39 $135,793 - $185,052
-133,131 Reduced 29.2%
322,829 $368,000
Q4 2022

Feb 14, 2023
BUY
$1.02 - $1.61 $275,719 - $435,203
270,313 Added 145.61%
455,960 $510,000
Q3 2022

Nov 14, 2022
BUY
$1.28 - $2.91 $237,628 - $540,232
185,647 New
185,647 $390,000

Others Institutions Holding RVLP

# of Institutions
1
Shares Held
92.5K
Call Options Held
0
Put Options Held
0
View Full List

About RVL Pharmaceuticals plc

RVLP Quotes by TradingView
  • Ticker RVLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,150,000
  • Description
  • RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...
More about RVLP
Track This Portfolio

Track Worth Venture Partners, LLC Portfolio

Follow Worth Venture Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worth Venture Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email